NovaBridge Biosciences
Buy Activity
Sell Activity
No financial data available for NBP.
Company may not file with SEC or CIK is unresolved.
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 2026-06-02 | Xu Cong Claire | SVP, Clinical Development | Sale | 3,494 | $3.94 | $14K | 290.2K | View | |
| 2026-05-14 | 2026-05-18 | Cao Sean Wuxiong | Director & See Remarks | Sale | 21.4K | $1.99 | $43K | 35.1K | View | |
| 2026-04-24 | 2026-04-28 | Hagler Mark Arnold | See Remarks | Purchase | 230.0K | $2.51 | $577K | 230.0K | View |
Informational purposes only, not investment advice.